Device / Technology News

RSS

TU Delft's nuclear research to be used for producing medical isotopes

TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.

27 Sep 2010

Bio-Dome wound interface dressings superior than GranuFoam

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results. The Engenex Negative Pressure Wound Therapy (NPWT) system's Bio-Dome wound interface showed superior tensile strength and lower simulated bioadhesion when compared with GranuFoam (polyurethane foam).

27 Sep 2010

FDA approves OZURDEX implant for uveitis treatment

Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.

27 Sep 2010

Stirling Products’ drug delivery technology interests big ‘pharma’

Healthcare group, Stirling Products Limited (ASX:STI) has advised that following the recent TeleMedCare e-health acquisition and the conditional addition of the recently announced pathology business (subject to due diligence completion and shareholder approval), the Company is now in process of its strategised business integration.

26 Sep 2010

Maine receives federal grants to upgrade electronic public health systems, scores of criminals provide home health care in Cal.

The Boston Globe: "Caritas Christi Health Care executives have told union negotiators they will shutter St. Elizabeth's Medical Center in Brighton and Carney Hospital in Dorchester if they can't close a deal for the six-hospital chain to be bought by a New York private equity firm. The warning was made during contract talks last week with the Massachusetts Nurses Association, according to two people who attended the meeting.

24 Sep 2010

Researchers create device to find ways to improve commonly used treatment for 'water on the brain'

Van Andel Research Institute (VARI) scientists participated in a study with researchers from the University of Utah that could help find ways to improve shunt systems used to treat the neurological disorder hydrocephalus, or "water on the brain," the leading cause of brain surgery for children in the United States. Researchers studied the shunt systems under a variety of conditions by creating a bioreactor that mimics the environment inside patients.

24 Sep 2010

Navilyst Medical to distribute VasoNova's VPS central venous catheter navigation technology

VasoNova announced a strategic partnership with Navilyst Medical Inc. today to distribute its VasoNova™ Vascular Positioning System™ VPS™ central venous catheter navigation technology.

24 Sep 2010

Cook Medical submits PMA to FDA for new balloon expandable stent for renal artery disease

Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its new balloon expandable stent for renal artery disease. Intended for patients suffering from renal artery stenosis, a narrowing of the arteries that supply blood to the kidneys, the new device features a low profile design and does not shorten upon expansion.

24 Sep 2010

Hyland Software announces acquisition of Computer Systems Company

Hyland Software has purchased privately held Computer Systems Company, Inc. (dba The CSC Group), a provider of business and clinical healthcare software and document conversion services. Terms of the transaction were not disclosed.

24 Sep 2010

FDA grants ArthroCare marketing clearance for Parallax Contour Vertebral Augmentation Device

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Parallax® Contour® Vertebral Augmentation Device (Contour) specifically for void creation in a vertebral body followed by injection of bone cement. Vertebral body void creation followed by bone cement augmentation is commonly used to treat painful vertebral compression fractures.

24 Sep 2010

Gore completes enrollment in study of VIABAHN Endoprosthesis with Heparin Bioactive Surface

W. L. Gore & Associates (Gore) reported the complete enrollment in a post-market approval study designed to better characterize the performance of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in treating peripheral vascular disease (PVD) of the superficial femoral artery (SFA). The 11 participating sites enrolled a total of 120 patients in the Gore VIPER (GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface for SuPERficial Femoral Artery Endoluminal Bypass) Study since initiation.

24 Sep 2010

OrbusNeich completes enrollment in Combo Bio-engineered Sirolimus Eluting Stent clinical trial

OrbusNeich today announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington the completion of patient enrollment in the randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) with 183 patients included at sites in Asia, Australia, Europe and South America.

24 Sep 2010

SurgiCount Safety-Sponge System reduces retained surgical sponges

SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce retained foreign objects will be presented and discussed at two upcoming conferences.

24 Sep 2010

NSBRI project to develop LTM/iRevive system for astronauts’ medical care

On an exploration mission, an astronaut has an accident and appears to have serious injuries as the spacecraft speeds to its destination. The ensuing scene is hectic as the other crew members try to get a grasp on the situation and provide appropriate treatment. Efficient use of time and resources may be the difference between life and death.

24 Sep 2010

OSU Medical Center implements FairWarning patient privacy solution

FairWarning, Inc., a leading global supplier of solutions which monitor and protect patient privacy in Electronic Health Records, today announced that Ohio State University Medical Center has selected FairWarning® 2.9.2 to enhance their patients' privacy.

24 Sep 2010

Progress in realizing potential of satellite measurements of air pollution

In many developing countries, the absence of surface-based air pollution sensors makes it difficult, and in some cases impossible, to get even a rough estimate of the abundance of a subcategory of airborne particles that epidemiologists suspect contributes to millions of premature deaths each year. The problematic particles, called fine particulate matter (PM2.5), are 2.5 micrometers or less in diameter, about a tenth the fraction of human hair. These small particles can get past the body's normal defenses and penetrate deep into the lungs.

24 Sep 2010

Aortic stent graft market in Latin America to expand to over $150M by 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Latin American physicians will increasingly adopt abdominal and thoracic endovascular aortic repair in place of surgical repair through 2015 as awareness of the benefits of endovascular techniques grows and physician training improves.

24 Sep 2010

Study: PTNS offers an effective treatment option for detrusor overactivity incontinence

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of a study "Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence Are Not Due to a Placebo Effect A Randomized, Double-Blind, Placebo Controlled Trial," to be published in the November 2010 print edition of THE JOURNAL OF UROLOGY.

24 Sep 2010

Preclinical data of novel drug-resistant hypertension therapy presented at TCT 2010

Preclinical data of a novel therapy designed to treat drug-resistant hypertension (high blood pressure) was presented Tuesday, September 21st, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Conference in Washington, DC, by Christopher D. Owens, MD, MSc, Assistant Professor in Residence, Division of Vascular and Endovascular Surgery, University of California, San Francisco.

24 Sep 2010

Cerus receives $1.4 million to support development of INTERCEPT red blood cell system

Cerus Corporation announced today that it has received an additional $1.4 million from the U.S. Department of Defense to support advanced development of the company's pathogen inactivation technology for red blood cells. The INTERCEPT red blood cell system is a pathogen inactivation product Cerus is developing to prevent the transmission of infectious diseases through red blood cell transfusions.

24 Sep 2010

Device / Technology News

TU Delft's nuclear research to be used for producing medical isotopes

Bio-Dome wound interface dressings superior than GranuFoam

FDA approves OZURDEX implant for uveitis treatment

Stirling Products’ drug delivery technology interests big ‘pharma’

Maine receives federal grants to upgrade electronic public health systems, scores of criminals provide home health care in Cal.

Researchers create device to find ways to improve commonly used treatment for 'water on the brain'

Navilyst Medical to distribute VasoNova's VPS central venous catheter navigation technology

Cook Medical submits PMA to FDA for new balloon expandable stent for renal artery disease

Hyland Software announces acquisition of Computer Systems Company

FDA grants ArthroCare marketing clearance for Parallax Contour Vertebral Augmentation Device

Gore completes enrollment in study of VIABAHN Endoprosthesis with Heparin Bioactive Surface

OrbusNeich completes enrollment in Combo Bio-engineered Sirolimus Eluting Stent clinical trial

SurgiCount Safety-Sponge System reduces retained surgical sponges

NSBRI project to develop LTM/iRevive system for astronauts’ medical care

OSU Medical Center implements FairWarning patient privacy solution

Progress in realizing potential of satellite measurements of air pollution

Aortic stent graft market in Latin America to expand to over $150M by 2015

Study: PTNS offers an effective treatment option for detrusor overactivity incontinence

Preclinical data of novel drug-resistant hypertension therapy presented at TCT 2010

Cerus receives $1.4 million to support development of INTERCEPT red blood cell system

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Latest News